EOC represents a group of heterogeneous disease entities. Five major categories of EOC exist, with differing cellular origins, hereditary implications, molecular alterations and potential for targeted therapies (Figure 1). In general, to promote consistency and uniformity, pathology review by a BC Cancer accredited tumour group pathologist is recommended.
** Other rare subtypes not listed include carcinosarcoma (Malignant Mixed Mullerian Tumour, MMMT), undifferentiated carcinoma and malignant Brenner tumour.
Click
here to download a larger version of Figure 1.
